|
Jun 11
|
Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee
|
|
May 22
|
Pacira BioSciences (NASDAQ:PCRX) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 57%
|
|
Mar 2
|
Is Pacira BioSciences, Inc. (PCRX) the Best Small Cap Pharma Stock to Buy Now?
|
|
Mar 2
|
Earnings Update: Here's Why Analysts Just Lifted Their Pacira BioSciences, Inc. (NASDAQ:PCRX) Price Target To US$31.71
|
|
Feb 28
|
Q4 2024 Pacira Biosciences Inc Earnings Call
|
|
Feb 28
|
Pacira BioSciences Inc (PCRX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...
|
|
Feb 27
|
Pacira: Q4 Earnings Snapshot
|
|
Feb 27
|
Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results
|
|
Feb 27
|
Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio
|
|
Feb 26
|
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March
|
|
Feb 20
|
Why Pacira (PCRX) is a Top Momentum Stock for the Long-Term
|
|
Feb 20
|
Pacira to Report 2024 Financial Results on Thursday February 27, 2025
|
|
Jan 2
|
Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|